Hematopoiesis News Volume 14.39 | Oct 3 2023

    0
    14







    2023-10-03 | HN 14.39


    Hematopoiesis News by STEMCELL Technologies
    Vol. 14.39 – 3 October, 2023
    TOP STORY

    BRCC3-Mediated NLRP3 Deubiquitylation Promotes Inflammasome Activation and Atherosclerosis in Tet2 Clonal Hematopoiesis

    Researchers used cholesterol-loaded Tet methylcytosine dioxygenase 2 (TET2)-deficient murine and embryonic stem cell–derived isogenic human macrophages to evaluate mechanisms of NLRP3 inflammasome activation in vitro.
    [Circulation]

    Abstract
    Explore the Science Events Calendar to discover conferences, podcasts, webinars, and more!
    PUBLICATIONSRanked by the impact factor of the journal

    A T Cell Receptor Targeting a Recurrent Driver Mutation in FLT3 Mediates Elimination of Primary Human Acute Myeloid Leukemia In Vivo

    Investigators identified a T cell receptor reactive to the recurrent D835Y driver mutation in the FMS-related receptor tyrosine kinase 3 tyrosine kinase domain (TCRFLT3D/Y). TCRFLT3D/Y-redirected T cells selectively eliminated primary human AML cells harboring the FLT3D835Y mutation in vitro and in vivo.
    [Nature Cancer]

    Full ArticlePress Release

    Epitope-Engineered Human Hematopoietic Stem Cells Are Shielded from CD123-Targeted Immunotherapy

    Scientists demonstrated that epitope-engineered HSPCs were shielded from CD123-targeted immunotherapy but remained functional, while CD123-deficient HSPCs displayed a competitive disadvantage.
    [Journal Of Experimental Medicine]

    Full Article
    Graphical Abstract

    mTORC1-Selective Activation of Translation Elongation Promotes Disease Progression in Chronic Lymphocytic Leukemia

    Investigators highlighted the importance of translation elongation as a driver of disease progression and identified inactivation of eEF2 activity as a novel therapeutic target for blocking chronic lymphocytic leukemia progression.
    [Leukemia]

    Full ArticleGraphical Abstract

    Reticulocytes in Donor Blood Units Enhance Red Blood Cell Alloimmunization

    Researchers tested whether reticulocytes in donor red blood cell (RBC) units could enhance RBC alloimmunization. Using a murine model, they demonstratedthat transfusing donor RBC units with increased reticulocyte frequencies dose-dependently increased RBC alloimmunization rates and alloantibody levels.
    [Haematologica]

    Full Article

    Targeting Cis-Regulatory Elements of FOXO Family Is a Novel Therapeutic Strategy for Induction of Leukemia Cell Differentiation

    Investigators showed that pharmacological inhibition of a common cis-regulatory element of forkhead box O (FOXO) family members successfully induced cell differentiation in various AML cell lines.
    [Cell Death & Disease]

    Full ArticleGraphical Abstract

    Role of YAP in Hematopoietic Differentiation and Erythroid Lineage Specification of Human-Induced Pluripotent Stem Cells

    Scientists investigated the role of YAP during the hematopoietic differentiation of human induced pluripotent stem cells (hiPSCs) to hematopoietic stem/progenitor cells and erythrocytes using the isogenic YAP-overexpressing and YAP-depleting hiPSCs to eliminate the effects of a genetic background variation.
    [Stem Cell Research & Therapy]

    Full Article

    T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplant for the Treatment of Fanconi Anemia and MDS/AML

    Researchers retrospectively evaluated the outcomes of 30 patients with Fanconi anemia and myelodysplastic syndrome/AML who underwent first allogeneic hematopoietic stem cell transplantation with a T cell-depleted graft at our institution.
    [Bone Marrow Transplantation]

    Abstract

    A Pilot Study of Cord Blood-Derived Natural Killer Cells As Maintenance Therapy after Autologous Hematopoietic Stem Cell Transplantation

    Investigators expanded cord blood-derived natural killer (CB-NK) cells ex vivo from random donors and investigated the feasibility and efficacy of repeated infusions CB-NK cells as maintenance therapy after autologous hematopoietic stem cell transplantation.
    [Annals Of Hematology]

    Abstract
    Dr. Jackie Damen discusses why the CFU assay should be a vital part of your cell therapy workflow in this on-demand webinar.
    REVIEWS

    The Contribution of the AT1 Receptor to Erythropoiesis

    The authors present evidence supporting that angiotensin II modulates physiological and pathological erythropoiesis processes trough the AT1 receptor.
    [Biochemical Pharmacology]

    Full ArticleGraphical Abstract

    The Evolving Views of Hematopoiesis: from Embryo to Adulthood and from In Vivo to In Vitro

    Scientists review the evolving views of HSPC biology during developmental and postnatal hematopoiesis. Moreover, we discuss recent advances in the in vitro induction and expansion of HSPCs, with a focus on the implications for clinical applications.
    [Journal Of Genetics And Genomics]

    Full ArticleGraphical Abstract
    INDUSTRY AND POLICY NEWS

    Smart Immune Doses First Leukemia Patients with ProTcell Therapy SMART101 in ReSET-02 Phase I/II Trial

    Smart Immune announced that the first patients have been dosed in its ReSET-02 Phase I/II trial for adult acute leukemia and myelodysplasia syndrome patients. Two patients have now received the first dose level of SMART101, an allogeneic cell therapy produced from donor-mobilized peripheral blood stem cells.
    [Smart Immune]

    Press Release
    FEATURED EVENT

    Till & McCulloch Meetings 2023

    October 23 – 25, 2023
    Toronto, Ontario, Canada

    > See All Events

    JOB OPPORTUNITIES

    Oncologist – Leukemia

    University of Nebraska Medical Center – Omaha, Nebraska, United States

    Director – Francis Owen Blood Research Laboratory

    University of North Carolina at Chapel Hill – Chapel Hill, North Carolina, United States

    Faculty Positions – Cancer Research

    Houston Methodist Research Institute – Houston, Texas, United States

    Investigator – Hematopoiesis

    Versiti Blood Research Institute, – Wisconsin Rapids, Wisconsin, United States

    Faculty Positions – Cancer Metastasis

    The Sidney Kimmel Cancer Center – Philadelphia, Pennsylvania, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Hematopoiesis News Twitter